Table 1.
Observed and estimated means, standard deviations, confidence intervals and effect sizes (Cohen's d) for the overall sample.
| Observed means |
Estimated marginal means |
Within group effect sizes (based on estimated means) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | 3-month follow-up | Pre-treatment | Post-treatment | 3-month follow-up | Pre-post | Pre-treatment to 3-month follow-up | Post-treatment to 3-month follow-up | |
| PHQ-9 | 12.53 (4.66) | 6.60 (4.65) | 5.70 (4.42) | 12.54 (4.48) | 6.72 (3.87) | 5.80 (3.68) | 1.39 (0.50–2.20) | 1.64 (0.71–2.47) | 0.24 (− 0.54–1.01) |
| GAD-7 | 11.15 (5.46) | 6.00 (3.37) | 5.00 (5.06) | 11.15 (5.25) | 6.06 (3.14) | 5.05 (4.21) | 1.18 (0.31–1.97) | 1.28 (0.40–2.08) | 0.27 (− 0.51–1.04) |
| SDS | 24.15 (13.37) | 8.90 (9.53) | 7.00 (7.16) | 24.15 (12.84) | 8.92 (7.93) | 6.88 (5.96) | 1.43 (0.53–2.24) | 1.72 (0.78–2.56) | 0.29 (− 0.49–1.05) |
| K10 | 29.62 (8.10) | 18.60 (6.40) | 18.90 (9.45) | 29.62 (7.78) | 18.81 (5.34) | 19.11 (7.87) | 1.62 (0.69–2.45) | 1.34 (0.45–2.15) | − 0.05 (− 0.81–0.0.72) |
Note: Standard deviations and 95% confidence intervals are shown in parentheses. Pre: pre-treatment, post: post-treatment; PHQ-9: Patient Health Questionnaire 9-Item; GAD-7: Generalised Anxiety Disorder 7-Item; SDS: Sheehan Disability Scale; K10: Kessler 10-Item.